Drug-Eluting versus Bare-Metal Stents in Large Coronary Arteries

2010266 citationsJournal Articlebronze Open Access

Authors

Christoph Kaiser · University Hospital of Basel

S. Galatius · Gentofte Hospital

Paul Erné · State Hospital

Franz R. Eberli · Triemli Hospital

Hannes Alber · University Hospital Innsbruck

Hans Rickli · State Hospital

Giovanni Pedrazzini ·

Abstract

In patients requiring stenting of large coronary arteries, no significant differences were found among sirolimus-eluting, everolimus-eluting, and bare-metal stents with respect to the rate of death or myocardial infarction. With the two drug-eluting stents, similar reductions in rates of target-vessel revascularization were seen. (Funded by the Basel Cardiovascular Research Foundation and the Swiss National Foundation for Research; Current Controlled Trials number, ISRCTN72444640.).

Topics & Keywords

Coronary Interventions and Diagnostics Cardiac Valve Diseases and Treatments Acute Myocardial Infarction Research

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 363, Issue 24, pp. 2310-2319

DOI: 10.1056/nejmoa1009406

Field-Weighted Citation Impact: 32.59